Brett West is currently the director of research at Morinda. Since joining the
company in 1997 he has held positions as senior laboratory manager, research chemist and toxicologist.
For more than 15 years, Mr. West has been involved in the scientific research of Noni and has also conducted
and published research on the efficacy, safety, and biologically active constituents of other medicinal
plants. He has developed and validated more than two dozen chemical and biological tests for in-house use by
Morinda’s laboratories, including anti-glycation, antioxidant and DNA protection tests.
His professional memberships have included the American Chemical Society, the International Society of
Regulatory Toxicology and Pharmacology, the Western Pharmacology Society, New York Academy of Sciences, and
the Institute of Food Technologists. He has degrees in molecular biology and pharmacology/toxicology from
Brigham Young University and the University of Arizona and is the editor-in-chief of the Journal of Medicinal
Mr. West has also published more than 50 peer reviewed scientific articles in various medical, chemistry, and
biological science journals including: Food Science & Nutrition, Journal of Medicinal Plant Research, Advance
Journal of Food Science and Technology, The Journal of Toxicological Sciences and Journal of Natural
Dr. Uribarri is a professor of medicine and Director of the Home Dialysis
Program at The Mount Sinai School of Medicine in New York City.
A renowned expert in kidney disease and hypertension, Dr. Uribarri has spent decades investigating the causes
of kidney disease, a common complication of diabetes and biological aging. Together with Dr. Helen Vlassara,
director of the Diabetes and Aging Division at The Mount Sinai School of Medicine, Dr. Uribarri was among the
first to explore food AGEs and their effects in healthy people as well as those with kidney disease or
diabetes. He was instrumental in establishing the first AGE food database.
He has published more than 100 articles in various medical journals and is a key contributor to The AGE-less
Dr. Andries Smit founded DiagnOptics Technologies BV in 2003 and has been the
medical director since 2004. DiagnOptics develops and markets a non-invasive diagnostic technology, which can
assess the tissue accumulation of Advanced Glycation Endproducts (AGEs).
For more than 15 years, he has been the head of the Vascular Unit of the University Medical Center Groningen
in the Netherlands and has authored or co-authored more than 200 scientific publications.
Dr. Smit was trained in internal medicine and is associate professor in hypertension and atherosclerosis.
Dr. Alin Stirban is the Director of Endocrinology and Diabetes Complications at
for Metabolic Research in Neuss, Germany. His expertise is centered on Diabetic Neuropathy and in vivo effects
of AGEs. He completed
his degrees in Human Medicine at Iuliu Hatieganu University in Romania and Journalistic Education from
Babes-Bolyai University in Romania,
and completed his Doctorate Thesis at Heinrich-Heine University in Germany.
Dr. Stirban serves as editor for several websites for medical professionals and for Germany’s “Diabetes
Journal.” He has published
several research publications regarding diabetes and AGEs. Additionally, he has been a Founding Member of the
Romanian Society for
Neuropathy, a Board Member of the Neuropathy Working Group of the German Diabetes Association and a Scientific
Board Member for the
Society of Biofactors. He has also served for nearly 10 years as the President of the German-Romanian
Association for the Study of
Diabetes Complications, and works as a professor at Heinrich-Heine University in Dusseldorf and as a doctor
for various Diabetes